Portacaval Shunt in Two Patients with Homozygous Type II Hyperlipoproteinaemia
Overview
Affiliations
We report the clinical and biochemical course of 2 patients who underwent portacaval shunting for the relief of homozygous type II hyperlipoproteinaemia. In our first patient, the initial favourable clinical and biochemical response subsequently deteriorated and a splenoportogram revealed the presence of a blocked splenic vein with a large collateral blood supply to the liver. The second patient has responded quite dramatically; there has been relief of her preoperative anginal attacks and a significant fall in her plasma cholesterol concentration. The present role of portacaval shunts in the management of this conditions is discussed.
Portacaval shunt in patients with familial hypercholesterolemia.
Starzl T, Chase H, AHRENS Jr E, McNamara D, Bilheimer D, Schaefer E Ann Surg. 1983; 198(3):273-83.
PMID: 6615051 PMC: 1353292. DOI: 10.1097/00000658-198309000-00004.
McNamara D, AHRENS Jr E, Kolb R, Brown C, Parker T, Davidson N Proc Natl Acad Sci U S A. 1983; 80(2):564-8.
PMID: 6572906 PMC: 393420. DOI: 10.1073/pnas.80.2.564.
The Eck fistula in animals and humans.
Starzl T, Porter K, Francavilla A Curr Probl Surg. 1983; 20(11):687-752.
PMID: 6357642 PMC: 3154772. DOI: 10.1016/s0011-3840(83)80010-0.
Portacaval shunt and hyperlipidemia.
Starzl T, Putnam C, Koep L Arch Surg. 1978; 113(1):71-4.
PMID: 202223 PMC: 3221468. DOI: 10.1001/archsurg.1978.01370130073012.